Abstract: Provided is a hydrophilic phosphorus ligand with the structure of formula 1. X is Y is m is an integer from 1 to 20, A independently is *āO(CH2)nā, n is an integer from 1 to 5, *ā is a bond close to triphenylphosphine, and ā is a bond away from triphenylphosphine.
Type:
Grant
Filed:
July 11, 2022
Date of Patent:
October 31, 2023
Assignee:
Industrial Technology Research Institute
Abstract: The present invention relates to RNA interference-based methods for inhibiting the expression of the DUX4 gene, a double homeobox gene on human chromosome 4q35. Recombinant adeno-associated viruses of the invention deliver DNAs encoding microRNAs that knock down the expression of DUX4. The methods have application in the treatment of muscular dystrophies such as facioscapulohumeral muscular dystrophy.
Type:
Grant
Filed:
March 12, 2019
Date of Patent:
October 31, 2023
Assignee:
RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
Inventors:
Scott Quenton Harper, Jian Liu, Sara Coppens, Lindsay Wallace
Abstract: This invention provides novel oral dosage forms comprising a hops extract. The oral dosage forms are capable of activating bitter taste receptors expressed in the gastrointestinal tract. The applications include but are not limited to the use of the oral dosage forms for reducing energy intake and/or appetite in a subject.
Type:
Grant
Filed:
April 23, 2018
Date of Patent:
October 31, 2023
Assignee:
THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED
Inventors:
John Ronald Ingram, Edward George Walker
Abstract: The present invention relates to compositions and methods for treating diseases, disorders or conditions associated with the expression of the glycosyl-phosphatidylinositol (GPI)-linked GDNF family protein ?-receptor 4 (GFR?4).
Type:
Grant
Filed:
September 29, 2020
Date of Patent:
October 31, 2023
Assignees:
The Trustees of the University of Pennsylvania, The Scripps Research Institute
Inventors:
Donald L. Siegel, Vijay Bhoj, Christoph Rader, Rebecca Goydel
Abstract: The present disclosure provides antibody sequences found in antibodies that bind to human CD25. In particular, the present disclosure provides sequences of anti-human CD25 antibodies, which do not block the binding of CD25 to IL-2 or IL-2 signalling. Antibodies and antigen-binding portions thereof including such sequences can be used in pharmaceutical composition and methods of treatment, in particular for treating cancer.
Type:
Grant
Filed:
February 5, 2020
Date of Patent:
October 31, 2023
Assignees:
Tusk Therapeutics Ltd., Cancer Research Technology Limited
Inventors:
Anne Goubier, Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown, Sergio Quezada, James Geoghegan, Bianka Prinz
Abstract: A comprehensive reconstruction method for long-series sediment data in data-lacking areas includes steps of: collecting hydrological and sediment data of a target river section; calculating sediment data in data-rich years with a flow-sediment content annual relationship curve method; calculating sediment data in only water quality and sediment test years with a correlation method between water quality and sediment data and hydrological station sediment data; calculating sediment data in data-lacking years with an adjacent station same year flow-sediment content relationship curve method; and calculating sediment data in remaining years with a multi-year average flow-sediment content relationship curve method.
Type:
Grant
Filed:
March 9, 2021
Date of Patent:
October 31, 2023
Assignee:
Chang Jiang River Scientific Research Institute
Inventors:
Jinqiong Zhao, Jinyou Lu, Shiming Yao, Min Wang, Hua Ge, Zhanfeng Cui, Jie Zhang, Ping Gong
Abstract: The present invention relates to: A schizophrenia animal model wherein the model is a mouse in which an anoctamin 1 (ANO1) gene is knocked out in cholinergic neurons of a medial habenula; and a preparation method therefor and the like. The schizophrenia animal model according to the present invention targets the medial habenula which is brain tissue playing a major role in the pathogenesis of schizophrenia, and it has been confirmed that when the ANO1 gene is specifically knocked out in the cholinergic neurons of the medial habenula, positive, negative and cognitive symptoms of schizophrenia are observed, thereby confirming that schizophrenia has been induced. Therefore, the animal model of the present invention is expected to be effectively useful in schizophrenia pathogenesis research and therapeutic agent development and screening.
Type:
Grant
Filed:
July 20, 2018
Date of Patent:
October 31, 2023
Assignee:
Korea University Research and Business Foundation
Inventors:
Jae-Yong Park, Eun Mi Hwang, Heh-In Im, Chang-Hoon Cho, Sangjoon Lee
Abstract: The present invention relates to the use of pomegranate oil and fractions thereof for preventing and treating neurodegenerative diseases. Particularly, the present invention relates to emulsions of the pomegranate oil or fractions thereof for the prevention and treatment of brain diseases, including Creutzfeldt-Jacob disease (CJD) and multiple sclerosis (MS).
Type:
Grant
Filed:
November 8, 2018
Date of Patent:
October 31, 2023
Assignees:
Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Abstract: The present disclosure provides antibody sequences found in antibodies that bind to human CD25, in particular an anti CD25-a-634 antibody which do not block the binding of CD25 to IL-2 or IL-2 signalling. Antibodies and antigen-binding portions thereof including such sequences can be used in pharmaceutical compositions and methods of treatment, in particular for treating cancer.
Type:
Grant
Filed:
March 13, 2019
Date of Patent:
October 31, 2023
Assignees:
Tusk Therapeutics Ltd., Cancer Research Technology Limited
Inventors:
Anne Goubier, Beatriz Goyenechea Corzo, Josephine Salimu, Kevin Moulder, Pascal Merchiers, Mark Brown, James Geoghegan, Bianka Prinz, Sergio Quezada
Abstract: Nanoassembly methods for producing quasi-3D plasmonic films with periodic nanoarrays of nano-sized surface features. A sacrificial layer is deposited on a surface of a donor substrate having periodic nanoarrays of nanopattern features formed thereon. A plasmon film is deposited onto the sacrificial layer and a dielectric spacer is deposited on the plasmon film. The donor substrate having the sacrificial layer, plasmon film, and dielectric spacer thereon is immersed in a bath of etchant to selectively remove the sacrificial layer such that the plasmon film and the dielectric spacer thereon adhere to the surface of the donor substrate. The dielectric spacer and the plasmon film are mechanically separated from the donor substrate to define a quasi-three dimensional (3D) plasmonic film having periodic nanoarrays of nano-sized surface features defined by the nanopattern features of the donor substrate surface. The quasi-3D plasmonic film is then applied to a receiver substrate.
Type:
Grant
Filed:
December 2, 2022
Date of Patent:
October 31, 2023
Assignee:
Purdue Research Foundation
Inventors:
Chi Hwan Lee, Zahyun Ku, Augustine Michael Urbas, Bongjoong Kim
Abstract: The present disclosure provides a method for reducing the inhalation of microorganisms, a washable mask for reducing the inhalation of microorganisms, applications of the mask and a method for manufacturing the same. The method for reducing the inhalation of microorganisms includes the steps of: providing a mask with a breathing zone, the breathing zone being used for covering a breathing part of a user; arranging two or more magnets around the breathing zone of the mask, the magnets generating a three-dimensional magnetic field, so as to change the moving trajectories of charged microorganisms in gas to be inhaled thereby increasing the probability of the microorganisms being captured by the filtering material.
Type:
Grant
Filed:
January 31, 2019
Date of Patent:
October 31, 2023
Assignee:
The Hong Kong Research Institute of Textiles and Apparel Limited
Inventors:
Lei Yao, Xiao Liao, Yongli Wang, Siyu Lin
Abstract: An audio encoding/decoding apparatus and method using vector quantized residual error features are disclosed. An audio signal encoding method includes outputting a bitstream of a main codec by encoding an original signal, decoding the bitstream of the main codec, determining a residual error feature vector from a feature vector of a decoded signal and a feature vector of the original signal, and outputting a bitstream of additional information by encoding the residual error feature vector.
Type:
Grant
Filed:
April 1, 2022
Date of Patent:
October 31, 2023
Assignees:
Electronics and Telecommunications Research Institute, Gwangju Institute of Science and Technology
Abstract: Provided herein is a method, apparatus, and system for detecting conditions indicative of an attempt to attach a skimming device to a payment device. Methods may include monitoring at least one wire among a plurality of wires between a card reader device and a motherboard; determining voltage consumption; determining current consumption; identifying a change in voltage consumption or current consumption satisfying a predetermined value; and providing for transmission of an alert of a condition indicating possible attachment of a card skimming device. Methods may include generating a status message periodically and transmitting the status message to a remote entity. The change in voltage consumption or current consumption satisfying the predetermined value may include a voltage instability exceeding a predetermined range about an anticipated voltage. The change in voltage consumption or current consumption satisfying the predetermined value may include a decrease in current satisfying the predetermined value.
Type:
Grant
Filed:
September 8, 2021
Date of Patent:
October 31, 2023
Assignee:
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Abstract: The disclosure provides for an isolated recombinant influenza virus having at least one of: a PA gene segment encoding PA with a residue at position 443 that is not arginine, a PB1 gene segment encoding PB1 with a residue at position 737 that is not lysine, a PB2 gene segment encoding PB2 with a residue at position 25 that is not valine or a residue at position 712 that is not glutamic acid, a NS gene segment encoding a NS1 with a residue at position 167 that is not proline, a HA gene segment encoding a HA with a residue at position 380 that is not threonine, or any combination thereof, and methods of making and using the virus.
Type:
Grant
Filed:
June 21, 2021
Date of Patent:
October 31, 2023
Assignee:
Wisconsin Alumni Research Foundation (WARF)
Abstract: A stably braking system and a method using the same control wheels on a single axle of a ground vehicle. Firstly, at least one of a wheel deceleration and an actual slip of each of the wheels is calculated. Hydraulic control commands are generated when a braking operation is performed in response to a braking indication signal and it is detected that the wheel deceleration or the actual slip is higher. The hydraulic control commands are configured to control a hydraulic braking system to adjust the wheel speed. When the ground vehicle drives in a straight line or turns with a first pose physical quantity, the hydraulic control command with a low priority is replaced by the hydraulic control command with a high priority and the hydraulic braking system is controlled to adjust the wheel speeds based on the identical hydraulic control commands.
Abstract: Predicting gastrointestinal impairment may involve obtaining intestinal sounds of a patient to generate audio data, identifying predefined spectral events in the audio data that are predictive of subsequent gastrointestinal impairment, the spectral events being defined by predefined parameters, and predicting the likelihood of subsequent gastrointestinal impairment relative to the identified spectral events.
Type:
Grant
Filed:
March 30, 2020
Date of Patent:
October 31, 2023
Assignee:
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
Abstract: A head-mounted eye tracking system including an optical combiner, an eye tracker and a signal processor is provided. The optical combiner includes an optical coupler. The eye tracker is at least partially disposed on the optical combiner and is suitable for sensing an eyeball movement of a wearer. The eye tracker includes a plurality of light-emitting devices and a plurality of sensing devices. The plurality of light-emitting devices are suitable for emitting tracking beams. The plurality of sensing devices are suitable for receiving the tracking beams reflected by the eyeball of the wearer. The signal processor is signally connected to the eye tracker.
Type:
Grant
Filed:
April 13, 2021
Date of Patent:
October 31, 2023
Assignee:
Industrial Technology Research Institute
Abstract: A system may include a non-intrusive sensor circuitry configured to provide electrical measurement data, including, for example, current data, voltage data, power factor data, active power consumption data, reactive power consumption data, or a combination thereof. A transient event detector may sweep the electrical measurement data with a first window and a second window, the first window adjacent to the second window. The transient event detector may identify a start and end of transient activity based on electrical measurement data referenced by separate adjacent windows. The transient event detector may capture a transient activity data segment comprising a portion of the electrical measurement data between first index and the second index.
Abstract: System, methods, and other embodiments described herein relate to improving the detection of traffic lights associated with a driving lane using a camera instead of map data. In one embodiment, a method includes estimating, from an image using a first model, depth and orientation information of traffic lights relative to a driving lane of a vehicle. The method also includes computing, using a second model, relevancy scores for the traffic lights according to geometric inferences between the depth and the orientation information. The method also includes assigning, using the second model, a primary relevancy score for a light of the traffic lights associated with the driving lane according to the depth and the orientation information. The method also includes executing a control task by the vehicle according to the primary relevancy score and a state confidence, computed by the first model, for the light.
Type:
Application
Filed:
April 22, 2022
Publication date:
October 26, 2023
Applicants:
Toyota Research Institute, Inc., Toyota Jidosha Kabushiki Kaisha
Inventors:
Kun-Hsin Chen, Kuan-Hui Lee, Chao Fang, Charles Christopher Ochoa